Abuse-resistant pain combo shows efficacy in late-stage study

09/10/2013 | Medscape (free registration)

An oral, extended-release combination of oxycodone and acetaminophen called MNK-795 was shown to be effective at controlling pain and to have abuse-deterrent properties that decrease its "likability," according to research presented at PAINWeek. Researchers compared the drug to a placebo and to Percocet in varying dosages.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA